1,225 Shares in Clorox Co (NYSE:CLX) Bought by Goelzer Investment Management Inc.
Goelzer Investment Management Inc. bought a new position in Clorox Co (NYSE:CLX) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,225 shares of the company’s stock, valued at approximately $212,000.
Other institutional investors have also recently modified their holdings of the company. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in Clorox by 21.1% in the 4th quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 305,672 shares of the company’s stock worth $46,933,000 after buying an additional 53,246 shares during the period. Bank of New York Mellon Corp lifted its stake in Clorox by 2.3% in the 4th quarter. Bank of New York Mellon Corp now owns 1,538,660 shares of the company’s stock worth $236,246,000 after purchasing an additional 34,403 shares in the last quarter. Brookstone Capital Management lifted its stake in Clorox by 2.0% in the 4th quarter. Brookstone Capital Management now owns 4,707 shares of the company’s stock worth $723,000 after purchasing an additional 92 shares in the last quarter. Cpwm LLC purchased a new stake in Clorox in the 4th quarter worth $202,000. Finally, Wedbush Securities Inc. lifted its stake in Clorox by 1.3% in the 4th quarter. Wedbush Securities Inc. now owns 5,181 shares of the company’s stock worth $795,000 after purchasing an additional 65 shares in the last quarter. 80.05% of the stock is owned by institutional investors.
In other Clorox news, SVP William S. Bailey sold 7,969 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $207.53, for a total transaction of $1,653,806.57. Following the completion of the transaction, the senior vice president now owns 15,172 shares in the company, valued at approximately $3,148,645.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Benno O. Dorer sold 252,794 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $169.01, for a total transaction of $42,724,713.94. Following the transaction, the chief executive officer now owns 306,908 shares of the company’s stock, valued at approximately $51,870,521.08. The disclosure for this sale can be found here. Insiders have sold 300,843 shares of company stock worth $52,556,301 over the last ninety days. 1.14% of the stock is owned by insiders.
Shares of Clorox stock opened at $209.83 on Friday. The stock has a market cap of $26.05 billion, a PE ratio of 30.77, a price-to-earnings-growth ratio of 5.13 and a beta of 0.24. The company has a debt-to-equity ratio of 3.69, a current ratio of 0.98 and a quick ratio of 0.72. The firm has a fifty day moving average price of $188.41 and a 200 day moving average price of $165.17. Clorox Co has a 1 year low of $144.12 and a 1 year high of $214.26.
Clorox (NYSE:CLX) last announced its earnings results on Friday, May 1st. The company reported $1.89 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.72 by $0.17. The business had revenue of $1.78 billion for the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.67% and a return on equity of 147.52%. The company’s revenue for the quarter was up 15.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.44 earnings per share. As a group, equities analysts expect that Clorox Co will post 6.89 EPS for the current year.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
See Also: Margin
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.